Chinese Hepatolgy ›› 2023, Vol. 28 ›› Issue (2): 189-192.

• Liver Cancer • Previous Articles     Next Articles

Retrospective cohort study on traditional chinese medicine dialectical treatment improving survival rate of patients with hepatocellular carcinoma after radical resection

HE Zheng-yang1, SHE Wei-ming2   

  1. 1. Department of Integrated TCM & Western Medicine, Shanghai Geriatrics Center, Shanghai 201104, China;
    2. Departement of Gastroenterology, Shanghai Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China
  • Received:2022-02-04 Online:2023-02-28 Published:2023-04-10
  • Contact: SHE Wei-ming,Email:she.weimin@zs-hospital.sh.cn

Abstract: Objective To evaluate the influence of traditional chinese medicine dialectical treatment on the survival rate and disease-free survival rate of patients with hepatocellular carcinoma after radical resection by retrospective cohort study. Methods A total of 619 patients with hepatocellular carcinoma who were followed up for more than 5 years after radical operation in two third-class hospitals in Shanghai were enrolled. Those who received traditional chinese medicine dialectical treatment for more than 6 months after operation were assigned as the Chinese and western medicine cohort, otherwise, they were assigned as the western medicine cohort.The clinical data of patients were collected and analyzed. Results 1. The 1, 2, 3 and 5-year disease-free survival rates of patients in western medicine cohort were 70.00%, 54.86%, 48.65% and 38.92% respectively; The 1, 2, 3 and 5-year disease-free survival rates of Chinese and Western medicine patients were 82.33%, 69.08%, 59.44% and 40.03% respectively. Log-rank test showed that there was no significant difference between the two groups (P=0.300), while Breslow test showed that there was significant difference between the two groups (P=0.026). 2.The 1, 2, 3 and 5-year overall survival rates of patients in western medicine cohort were 88.92%, 80.27%, 76.49% and 65.68% respectively. The 1, 2, 3 and 5-year overall survival rates of Chinese and Western medicine patients were 99.20%, 96.79%, 91.79% and 75.50% respectively. Log-rank test showed that the difference between the two cohorts was statistically significant (P=0.002). 3. By subgroup analysis of Chinese and Western medicine cohort, it was found that the 5-year survival rate of high exposure group (≥12 months) was significantly better than that of high exposure group (≥6 months and < 12 months).81.46% and 47.73% respectively (P<0.001). Conclusion For the patients after radical resection of hepatocellular carcinoma, the survival rate and survival time of patients in the TCM-WM group treated with traditional chinese medicine dialectical treatment are higher and longer than those in the Western medicine group. Among them, those who have been treated with traditional chinese medicine dialectical treatment for a long time (≥12 months) have higher survival rate and longer survival time.Compared with the western medicine group, TCM-WM group have higher disease-free survival rate and longer disease-free survival time in short-term. The disease-free survival condition of the TCM-WM groups is better than that of the western medicine group before 60 months, while the disease-free survival condition of the two groups tends to be the same after 60 months.

Key words: Hepatocellular carcinoma, Hepatectomy, Radiofrequency ablation, Traditional chinese medicine dialectical treatment, Cohort study